Ainos, a Cayman Islands corporation focused on advanced technology diagnostic medical devices and artificial intelligence consumer healthcare solutions, agreed to acquire a minority stake in Amarillo Biosciences, a company engaged in the discovery and development of pharmaceutical and biotech products, for $20m. "We believe this transaction will help the company to spearhead innovation in medical diagnostics and accelerate the company's path to product commercialization," Stephen T. Chen, Amarillo Biosciences Former Chairman & CEO.